Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6244092 | 0.95 | TBXAS1 (0.50) | TBXAS1MAPTCYP2D6PTPN1HSD11B1 | |
| Acetic Acid SCHEMBL28086771 | 0.86 | TBXAS1 (0.43) | TBXAS1MAPTCYP2D6ALDH1A1OXER1 | |
| Formamide SCHEMBL28077846 | 0.86 | TBXAS1 (0.43) | TBXAS1MAPTCYP2D6PTPN1OXER1 | |
| SCHEMBL7169853 | 0.80 | ALDH1A1 (0.37) | MAPTKDM4ETDP1ALDH1A1CHEK1 | |
| SCHEMBL14339188 | 0.77 | LTA4H (0.35) | TBXAS1MAPTALDH1A1L3MBTL1HTT | |
| SCHEMBL8127371 | 0.76 | TBXAS1 (0.55) | TBXAS1CYP2D6KDM4EALDH1A1L3MBTL1 | |
| SCHEMBL5425400 | 0.73 | L3MBTL1 (0.37) | MAPTKDM4ETDP1ALDH1A1CHEK1 | |
| SCHEMBL25515658 | 0.72 | KDM4E (0.38) | MAPTKDM4ETDP1ALDH1A1CHEK1 | |
| SCHEMBL25510071 | 0.70 | HTR2A (0.36) | MAPTKDM4ETDP1ALDH1A1CHEK1 | |
| SCHEMBL27283340 | 0.69 | CALM1 (0.42) | MAPTKDM4ETDP1ALDH1A1CHEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5134239-A | Quaterinary indolizine compound | THE DOW CHEMICAL COMPANY (US) | 1992-07-28 | — | — | US | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
| EP-3265447-B1 | BENZOXAZINE LOW TEMPERATURE CURABLE COMPOSITION | HUNTSMAN ADVANCED MAT AMERICAS LLC (US) | 2023-03-01 | — | — | EP | disclosed |
| CN-107428708-B | Benzoxazine low temperature curable compositions | 亨斯迈先进材料美国有限责任公司 | 2021-11-09 | — | — | CN | disclosed |
| US-20180030264-A1 | Benzoxazine Low Temperature Curable Composition | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC | 2018-02-01 | — | — | US | disclosed |
| EP-3265447-A1 | BENZOXAZINE LOW TEMPERATURE CURABLE COMPOSITION | Huntsman Advanced Materials Americas LLC (US) | 2018-01-10 | — | — | EP | disclosed |
| EP-0458502-B1 | Latent catalysts, cure-inhibited epoxy resin compositions and laminates prepared therefrom | DOW GLOBAL TECHNOLOGIES INC (US) | 2003-06-18 | — | — | EP | disclosed |
| CN-1050617-C | Latent catalysts, cure-inhibited epxoy resin compositions and laminates prepared therefrom | DOW CHEMICAL CO (US) | 2000-03-22 | — | — | CN | disclosed |
| CN-1050618-C | Latent Catalysts, Cure-inhibited epxoy resin compositions and laminates prepared therefrom | DOW CHEMICAL CO (US) | 2000-03-22 | — | — | CN | disclosed |
| CN-1035823-C | Process for preparing latent catalysts for curing epoxy resins | DOW CHEMICAL CO (US) | 1997-09-10 | — | — | CN | disclosed |
| EP-0328020-B1 | Use of a catalyst in epoxy compositions | DOW CHEMICAL CO (US) | 1996-10-09 | — | — | EP | disclosed |
| CN-1118793-A | Latent catalysts, cure-inhibited epxoy resin compositions and laminates prepared therefrom | DOW CHEMICAL CO (US) | 1996-03-20 | — | — | CN | disclosed |
| CN-1118794-A | Latent Catalysts, Cure-inhibited epxoy resin compositions and laminates prepared therefrom | DOW CHEMICAL CO (US) | 1996-03-20 | — | — | CN | disclosed |
| EP-0553887-A2 | Catalysts and epoxy resin composition containing the same | THE DOW CHEMICAL COMPANY (US) | 1993-08-04 | — | — | EP | disclosed |
| US-5169473-A | Complex of an onium, arsenic or amine compound and boric acid; advanced polyepoxides; storage stability | THE DOW CHEMICAL COMPANY (US) | 1992-12-08 | — | — | US | disclosed |
| US-5134239-A | Quaterinary indolizine compound | THE DOW CHEMICAL COMPANY (US) | 1992-07-28 | — | — | US | disclosed |
| CN-1056699-A | Latent catalysts and cure-inhibited epoxy resin compositions and laminates made therefrom | DOW CHEMICAL CO (US) | 1991-12-04 | — | — | CN | disclosed |
| EP-0458502-A2 | Latent catalysts, cure-inhibited epoxy resin compositions and laminates prepared therefrom | THE DOW CHEMICAL COMPANY (US) | 1991-11-27 | — | — | EP | disclosed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | disclosed |
| EP-0328020-A2 | Use of a catalyst in epoxy compositions | THE DOW CHEMICAL COMPANY (US) | 1989-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030264-A1 | Benzoxazine Low Temperature Curable Composition | CRYZ, PIEZO1, PSMD12 | TBXAS1 158/4885MAPT 553/4885CYP2D6 2296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.